Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
Sophie Testa, Paolo Prandoni, Oriana Paoletti, Rossella Morandini, Maurizio Tala, Claudia Dellanoce, Matteo Giorgi‐Pierfranceschi, Monia Betti, Gian Battista Danzi, Angelo Pan, Gualtiero Palareti
Topics & Concepts
MedicineRivaroxabanEdoxabanLopinavirDabigatranTrough levelCoronavirus disease 2019 (COVID-19)ApixabanPneumoniaInternal medicineAnesthesiaAtrial fibrillationWarfarinTransplantationInfectious disease (medical specialty)DiseaseTacrolimusCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and Thrombosis